Pharmacology: GLP-1 Receptor Agonists Flashcards

1
Q

what type of drug are GLP-1 receptor agonists

A

incretin, insulin secretagogues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the GLP-1 receptor agonists mechanism

A

GLP-1 like molecules modified to avoid the breakdown of DPP4, can also alter half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how do GLP-1 receptor agonists need to be administered

A

injection, not orally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how does the pharmacological effect of GLP-1 receptor agonists compare to that of DPP4i

A

far greater then DPP4i

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what action do GLP-1 receptor agonists have relevant to diabetes

A

act to promote insulin secretion in glucose dependant mechanism, also lowers glucagon(which is increased in T2DM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are some of the systemic actions of GLP-1 receptors

A

reduce appetite by acting on hypothalamus and act on intestine to reduce gastric emptying

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how potent are GLP-1 receptors

A

quite potent, reduce HbA1c by arund 11-15mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what effect do GLP-1 receptor agonists have on weight and BP

A
weight = 2-3kg loss
BP = lower
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the most commonly used GLP-1 receptor agonist

A

Liraglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are some of the side effects of GLP-1 receptor agonists

A

nausea, vomiting(improves after 6 weeks), gallstones risk increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what effect do GLP-1 receptor agonists have on CV risk

A

have been shown to reduce CV mortality by 12-20% for some GLP-1 RAs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

where do GLP-1 RAs fit in the step by step treatment of T2DM

A

second line in those with compelling reason to minimise hypoglycaemia, OR those with compelling reason to lose weight, OR if significant CV risk or disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly